Global Precision Medicine Market Report

September 22, 2017

Coherent Market Insights 

“Advancements in genomics and big data analytics are driving growth in the precision medicine market: Next-generation sequencing and genomic profiling technologies have advanced significantly in recent years, enabling better detection and understanding of diseases at the molecular level.”

 

The precision medicine market is projected to reach USD 92.31 billion by 2024, driven by innovations like FDNA’s Face2Gene platform. Face2Gene leverages artificial intelligence and deep learning to analyze facial features, aiding in the accurate expedited diagnosis of genetic disorders. This technology exemplifies the growing impact of AI in precision medicine, enabling personalized treatment plans based on individual genetic profiles. The market expansion reflects an increasing demand for tailored healthcare solutions and advanced decision support tools, underscoring the critical role of platforms like Face2Gene in revolutionizing patient care and improving health outcomes globally.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading